(Q37231865)

19 August 2017

1 reference

title

COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention (English)

1 reference

chronic obstructive pulmonary disease

19 August 2017

1 reference

David Mannino

6

0 references

Thierry Troosters

3

object named as

Thierry Troosters

1 reference

19 August 2017

1

Marc Decramer

1 reference

19 August 2017

7

Emiel Wouters

1 reference

19 August 2017

8

Sanjay Sethi

1 reference

19 August 2017

Stephen Rennard

2

1 reference

19 August 2017

Douglas W Mapel

4

1 reference

19 August 2017

Nicholas Giardino

5

1 reference

19 August 2017

Christopher B Cooper

9

1 reference

19 August 2017

language of work or name

English

0 references

publication date

1 August 2008

1 reference

COPD: Journal of Chronic Obstructive Pulmonary Disease

19 August 2017

1 reference

19 August 2017

5

1 reference

19 August 2017

235-256

1 reference

19 August 2017

4

1 reference

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary

19 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Chronic obstructive pulmonary disease: current burden and future projections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Low lung function and incident lung cancer in the United States: data From the First National Health and Nutrition Examination Survey follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The metabolic syndrome in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988-1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The risk of osteoporosis in Caucasian men and women with obstructive airways disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The potential impact of anaemia of chronic disease in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Are patients with COPD psychologically distressed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Mortality in COPD: Role of comorbidities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Chronic Obstructive Pulmonary Disease, inflammation and co-morbidity--a common inflammatory phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Raised CRP levels mark metabolic and functional impairment in advanced COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Upper airway mucosa temperature in obstructive sleep apnoea/hypopnoea syndrome, nonapnoeic snorers and nonsnorers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Maintenance therapy with budesonide and formoterol in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Contemporary management of chronic obstructive pulmonary disease: scientific review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Smoking and lung function of Lung Health Study participants after 11 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The TORCH (towards a revolution in COPD health) survival study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Exacerbations and time spent outdoors in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Local and systemic inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Enhanced neutrophil response in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Interleukin-6 causes myocardial failure and skeletal muscle atrophy in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Characteristics of physical activities in daily life in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Correlates of physical activity in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Contractile leg fatigue after cycle exercise: a factor limiting exercise in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Reduced muscle redox capacity after endurance training in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Mechanisms of disuse muscle atrophy: role of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Physical activity and modulation of systemic low-level inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

A qualitative study of compliance with medication and lifestyle modification in Chronic Obstructive Pulmonary Disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Dyspnea: the role of psychological processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Osteoporosis and male age-related hypogonadism: role of sex steroids on bone (patho)physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Longitudinal deteriorations in patient reported outcomes in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Effect of pulmonary rehabilitation on quadriceps fatiguability during exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Physiologic benefits of exercise training in rehabilitation of patients with severe chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Exercise training decreases ventilatory requirements and exercise-induced hyperinflation at submaximal intensities in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Combined physiological effects of bronchodilators and hyperoxia on exertional dyspnoea in normoxic COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The epidemiology of osteoporosis and fractures in geriatric medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The prevalence of vertebral deformity in european men and women: the European Vertebral Osteoporosis Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Osteoporosis prevention, diagnosis, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

A rational approach to evidence gaps in the management of osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Relationship of lung function to severity of osteoporosis in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Reduced pulmonary function in patients with spinal osteoporotic fractures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Strategies for the prevention of hip fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Prevalence of nutritional depletion in a large out-patient population of patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Prevalence of an elevated resting energy expenditure in patients with chronic obstructive pulmonary disease in relation to body composition and lung function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Total daily energy expenditure relative to resting energy expenditure in clinically stable patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Total free living energy expenditure in patients with severe chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Nutritional support in patients with chronic obstructive pulmonary disease during hospitalization for an acute exacerbation; a randomized controlled feasibility trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The prevalence of anxiety disorders in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The catastrophic misinterpretation of physiological distress.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Functional status and well being in chronic obstructive pulmonary disease with regard to clinical parameters and smoking: a descriptive and comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Functional impairment in COPD patients: the impact of anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Anxiety and depression in severe chronic obstructive pulmonary disease: the effects of pulmonary rehabilitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

High prevalence of anxiety symptoms in hospitalized geriatric patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Risk of depression in patients with chronic obstructive pulmonary disease and its determinants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Prevalence of depression in patients with chronic obstructive pulmonary disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Quality of life in patients with chronic obstructive pulmonary disease and comorbid anxiety or depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Mortality after hospitalization for COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Anxiety and depression in COPD patients: The roles of gender and disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Gender and COPD in patients attending a pulmonary clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Gender associated differences in determinants of quality of life in patients with COPD: a case series study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Major depression and activation of the inflammatory response system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Neuropsychiatric adverse effects of interferon-alpha: recognition and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Priming of experimental anxiety by repeated subthreshold GABA blockade in the rat amygdala.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Respiratory function, cognitions, and panic in chronic obstructive pulmonary patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Smoking and panic attacks: an epidemiologic investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Smoking and major depression. A causal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Impact of salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Psychological outcomes of an outpatient pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Ambulatory oxygen improves quality of life of COPD patients: a randomised controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The effects of running and meditation on beta-endorphin, corticotropin-releasing hormone and cortisol in plasma, and on mood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Effects of physical exercise on depression, neuroendocrine stress hormones and physiological fitness in adolescent females with depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Short- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Is cholinergic sensitivity a genetic marker for the affective disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Obstructive and restrictive lung disease and functional limitation: data from the Third National Health and Nutrition Examination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Neurohumoral activation as a link to systemic manifestations of chronic lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Obstructive lung disease deaths in the United States from 1979 through 1993. An analysis using multiple-cause mortality data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Comorbidity and mortality in COPD-related hospitalizations in the United States, 1979 to 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Mortality in relation to smoking: 50 years' observations on male British doctors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Pulmonary rehabilitation and the BODE index in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Smokers with airway obstruction are more likely to quit smoking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Loss of bone density with inhaled triamcinolone in Lung Health Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Prednisolone response in patients with chronic obstructive pulmonary disease: results from the ISOLDE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Dose response relation to oral theophylline in severe chronic obstructive airways disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Response of lung volumes to inhaled salbutamol in a large population of patients with severe hyperinflation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Improvement in Resting Inspiratory Capacity and Hyperinflation With Tiotropium in COPD Patients With Increased Static Lung Volumes *

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Effect of heliox on lung dynamic hyperinflation, dyspnea, and exercise endurance capacity in COPD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Effect of heliox breathing on dynamic hyperinflation in COPD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Effect of bronchoscopic lung volume reduction on dynamic hyperinflation and exercise in emphysema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Antiinflammatory effects of the phosphodiesterase-4 inhibitor cilomilast (Ariflo) in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Exercise capacity deterioration in patients with COPD: longitudinal evaluation over 5 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Exercise capacity and mortality among men referred for exercise testing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Daily activity energy expenditure and mortality among older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Age and gender differences in negative affect—Is there a role for emotion regulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Mitochondrial dysfunction in COPD patients with low body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Effect of Fluticasone Propionate/Salmeterol on Lung Hyperinflation and Exercise Endurance in COPD

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Systemic oxidative stress in asthma, COPD, and smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Expression of Adhesion Molecules and G Proteins in Circulating Neutrophils in Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Systemic effects of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Systemic Effects of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

Infections and Airway Inflammation in Chronic Obstructive Pulmonary Disease Severe Exacerbations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F15412550802237531

10.1080/15412550802237531

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference